You have no items in your shopping cart.
Human FGFa [orb3002326]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human FGF-19 [orb3002415]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.5 KDa. Observed: 26 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse FGFb [orb3002419]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.15 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Rat FGFb [orb3002420]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.2 KDa. Observed: 16 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μg - Human FGFb(K128N) [orb3002425]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.2 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFa [orb3002211]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-4 [orb3002220]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1 KDa. Observed: 14 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human FGF-17 [orb3002224]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.6 KDa. Observed: 22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KGF [orb3002467]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.9 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFb [orb3002475]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 16.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg